2nd Quarter - Amendment

WASHINGTON HEALTH STRATEGIES GROUP for ASSOCIATION OF CLINICAL RESEARCH ORGANIZATIONS

Firm
Client
Income
$30,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report Jul 26, 2016 $30,000 Replaced
2nd Quarter - Amendment (this page) Nov 30, 2016 $30,000 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

21st Century Cures, Conduct of Clinical Trials, FDA, NIH, R&D Tax Credit, Corporate Tax Reform, Drug Safety, Innovation for Healthier Americans

LobbyistCovered position, as disclosed
SABAH BHATNAGAR New —
JOHN LEWIS —
DOUGLAS PEDDICORD —

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.